Thrombosis in patients with myeloproliferative neoplasms. Case report
Thrombotic complications are the most significant factors determining the prognosis in myeloproliferative neoplasms. Markers for assessing the risk of thrombosis are the number of leukocytes, platelets, hemoglobin level, hematocrit, age, molecular status, history of thrombosis, obesity, arterial hyp...
Main Authors: | Anait L. Melikyan, Irina N. Subortseva, Elena A. Gilyazitdinova, Tamara I. Koloshejnova, Kristina S. Shashkina, Elena K. Egorova, Alla M. Kovrigina, Andrei B. Sudarikov, Lana A. Gorgidze |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2021-07-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/76322/56910 |
Similar Items
-
Clinical features and diagnosis of Ph - negative myeloproliferative neoplasms occurring in conjunction with the antiphospholipid syndrome
by: A L Melikyan, et al.
Published: (2019-07-01) -
Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: Treatment Considerations and Unmet Needs
by: Angela Liu, et al.
Published: (2022-12-01) -
Thrombosis in myeloproliferative neoplasms: A clinical and pathophysiological perspective
by: Sarah Kelliher, et al.
Published: (2021-12-01) -
Mechanisms of platelet activation in cancer-associated thrombosis: a focus on myeloproliferative neoplasms
by: Roelof H. Bekendam, et al.
Published: (2023-06-01) -
Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms
by: Eylem Eliaçık, et al.
Published: (2015-05-01)